Vitamin D inhibits growth of human airway smooth muscle cells through growth factor‐induced phosphorylation of retinoblastoma protein and checkpoint kinase 1
Open Access
- 28 October 2009
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 158 (6) , 1429-1441
- https://doi.org/10.1111/j.1476-5381.2009.00428.x
Abstract
Background and purpose: Airway remodelling in asthma is manifested, in part, as increased airway smooth muscle (ASM) mass, reflecting myocyte proliferation. We hypothesized that calcitriol, a secosteroidal vitamin D receptor (VDR) modulator, would inhibit growth factor‐induced myocyte proliferation. Experimental approach: Human ASM cell cultures were derived from bronchial samples taken during surgery. ASM cells were treated with platelet‐derived growth factor (PDGF) (10 ng·mL−1) for 24 h in the presence of calcitriol, dexamethasone or a checkpoint kinase 1 (Chk1) inhibitor (SB218078). The effects of calcitriol on PDGF‐mediated cell proliferation were assessed by thymidine incorporation assay, propidium iodide‐based cell cycle analysis, caspase‐3 assay and immunoblotting for specific cell cycle modulators. Key results: Calcitriol, but not dexamethasone, inhibited PDGF‐induced ASM DNA synthesis concentration dependently (IC50= 520 ± 52 nM). These effects were associated with VDR‐mediated expression of cytochrome CYP24A1 with no effects on ASM apoptosis. Calcitriol substantially inhibited (P < 0.01) PDGF‐stimulated cell growth in ASM derived from both normal (59 ± 8%) and asthmatic subjects (57 ± 9%). Calcitriol inhibited PDGF‐induced phosphorylation of retinoblastoma protein (Rb) and Chk1, with no effects on PDGF‐mediated activation of extracellular signal‐regulated kinases 1/2, PI3‐kinase and S6 kinase, or expression of p21Waf/Cip‐1, p27Kip1, cyclin D and E2F‐1. Consistent with these observations, SB218078 also inhibited (IC50= 450 ± 100 pM) PDGF‐induced cell cycle progression. Conclusions and implications: Calcitriol decreased PDGF‐induced ASM cell growth by inhibiting Rb and Chk1 phosphorylation. This Research Paper is the subject of a Commentary in this issue by Clifford and Knox (pp. 1426–1428). To view this article visit http://www3.interscience.wiley.com/journal/121548564/issueyear?year=2009Keywords
This publication has 47 references indexed in Scilit:
- The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of actionMolecular Aspects of Medicine, 2008
- Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cellsBritish Journal of Pharmacology, 2008
- Expanded Roles for Chk1 in Genome MaintenanceJournal of Biological Chemistry, 2008
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Vitamin D signalling pathways in cancer: potential for anticancer therapeuticsNature Reviews Cancer, 2007
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Exercising Restraints: Role of Chk1 in Regulating the Onset and Progression of Unperturbed Mitosis in Vertebrate CellsCell Cycle, 2007
- CD38 Expression Is Insensitive to Steroid Action in Cells Treated with Tumor Necrosis Factor-α and Interferon-γ by a Mechanism Involving the Up-Regulation of the Glucocorticoid Receptor β IsoformMolecular Pharmacology, 2006
- Tumor Necrosis Factor α Modulates Airway Smooth Muscle Function via the Autocrine Action of Interferon βJournal of Biological Chemistry, 2003
- Vitamin D3-induced Apoptosis of Murine Squamous Cell Carcinoma CellsJournal of Biological Chemistry, 2001